Dr. Richard Tsai received his undergraduate degree in molecular and cell biology at University of California, Berkeley and a joint MD/MBA degree at Drexel University. He completed a neurology residency at Albert Einstein College of Medicine in New York, serving as chief resident in his last year. He then completed a fellowship in behavioral neurology at the UCSF Memory and Aging Center. Dr. Tsai is the associate director of the Alzheimer’s Disease and Frontotemporal Dementia Clinical Trials Program and is active in leading and managing many neurodegenerative clinical trials. His interests are dementia therapeutics, clinical trials methodology and neurodegenerative biomarkers. In addition, Dr. Tsai is a member of the outreach team of the UCSF Alzheimer’s Disease Research Center and has an interest in health disparities among elderly Chinese Americans.